Applications of (D)-N-(Benzyloxycarbonyl)Pipecolic Acid in Industrial Manufacturing

As a specialized manufacturer of (D)-N-(Benzyloxycarbonyl)Pipecolic Acid, we supply this advanced protected amino acid intermediate to precision-driven sectors within regulated life science and chemical synthesis markets. Our product underpins high-purity transformations essential for complex molecule construction, and is backed by robust documentation supporting regulatory, formulation, and production control alignment in global supply chains.

1. Peptide API Intermediate Manufacturing

Peptide and pseudopeptide active pharmaceutical ingredients (APIs) depend on orthogonally protected amino acid building blocks for solid-phase and solution-phase synthesis. (D)-N-(Benzyloxycarbonyl)Pipecolic Acid acts as a key monomer where D-configuration and Z-protection maintain side-chain integrity and stereochemistry control. This substrate integrates into automated peptide synthesizers, facilitating reliable scale-up for clinical and commercial API lots.

Industry compliance standards

• ICH Q7 GMP for APIs
• US FDA 21 CFR Part 210/211
• European Pharmacopoeia (Ph. Eur.) monographs for peptides
• USP General Chapter <1045> Biotechnology-Derived Articles

Typical usage ratio

• 0.1–0.25 mole percent per coupling cycle depending on sequence length and synthetic route; adjusted based on peptide complexity

Downstream process integration

• Activated during stepwise elongation on peptide synthesizers, following Fmoc/Boc/N–protecting group protocols; undergoes cleavage/deprotection near the final purification step

Final product types

• Pharmaceutical peptide APIs for injectable, topical, and oral formulations
• Peptide reference standards for QC labs

2. Chiral Auxiliary for Asymmetric Synthesis

Synthetic chemists employ (D)-N-(Benzyloxycarbonyl)Pipecolic Acid as a chiral auxiliary or building block in diastereoselective transformations. Its configuration and protecting group enhance enantiomeric enrichment during alkylation, conjugate addition, and cyclization steps relevant to pharmaceutical and fine chemical manufacturing. Integration with flow chemistry and batch reactors drives high-value intermediate creation in cGMP environments.

Industry compliance standards

• EU REACH Registration (for chemical intermediates)
• ISO 9001:2015 Quality Management System
• Company-specific GMP alignment for chiral intermediates

Typical usage ratio

• 0.05–0.3 molar equivalents, calibrated per reaction scale and desired stereoselectivity; excess minimized to streamline downstream cleavage and recovery

Downstream process integration

• Introduced in the auxilliary attachment stage, followed by asymmetric induction and auxiliary removal in multi-step synthesis of chiral drugs and agrochemicals

Final product types

• Chiral pharmaceutical intermediates
• Agrochemical actives requiring D-configuration control

3. Protected Amino Acid for Custom Peptide Synthesis Services

Contract research and CMOs utilize (D)-N-(Benzyloxycarbonyl)Pipecolic Acid to build custom-sequence peptides for preclinical screening and biomarker validation. Its high-purity Z-protection supports reliable coupling and analytical traceability. The material is often shipped with CoA and trace impurity documentation, meeting global buyers’ expectations for characterized protected monomer supply.

Industry compliance standards

• IUPAC amino acid nomenclature conformity
• Syntheses subject to ISO/IEC 17025 accredited laboratory protocols
• Documentation for Research Use Only (RUO) in non-GMP settings

Typical usage ratio

• 0.08–0.18 mmol per resin loading (solid-phase synthesis); adjusted for peptide length and batch size

Downstream process integration

• Loaded during first or middle coupling cycles on automated SPPS lines; deprotected before final peptide cleavage and HPLC purification

Final product types

• Custom research peptides (screening, diagnostic, reference standards)
• Peptide libraries for SAR studies

4. Fine Chemical Intermediate for Heterocyclic Synthesis

Chemical companies use (D)-N-(Benzyloxycarbonyl)Pipecolic Acid as a regioselective intermediate for synthesizing functionalized heterocyclic scaffolds. The protected pipecolic backbone allows selective transformation without unwanted ring cleavage, supporting development of drug candidate scaffolds and biochemical probes in discovery projects. Strict substructure control is vital where heteroatom configuration determines final molecule activity.

Industry compliance standards

• ISO 9001:2015 Quality Management for chemical production
• EU REACH Pre-registration (as a research intermediate, if applicable)
• CLP Regulation (EC 1272/2008) classification for raw material handling

Typical usage ratio

• 5–15% molar basis relative to core heterocycle in stepwise construction; range adjusted according to substitution pattern and protection strategy

Downstream process integration

• Introduced post-activation to react with heteroatomic electrophiles, followed by strategic deprotection and cyclization in multi-step routes

Final product types

• Functionalized heterocyclic intermediates for pharmaceuticals
• Specialty ligands for catalysis and coordination chemistry